Zeolite detox myths busted: In lab tests, zeolites do NOT bind with aluminum, lead, uranium, mercury or cadmium… only CESIUM. Given that many people are consuming 15g daily of this zeolite powder, they are effectively swallowing 750 micrograms of lead each day, along with as much as 450mg of aluminum daily. Read more…
Background: When Sarah was diagnosed with cancer in 2013, her parents, Andy and Anna Hershberger, initially agreed to chemotherapy treatments. However, they opted to end such treatments when Sarah’s condition grew worse, fearing that the treatments themselves might eventually lead to her death.
As is typical in today’s post-constitutional America, officials at Akron Children’s Hospital responded with a legal attempt to strip Sarah’s parents of their right to choose their own daughter’s medical treatment. The hospital sought court permission to obtain “limited guardianship” over her, thereby giving them the authority over medical decisions pertaining to her. Doctors testified she would not make it six months without chemotherapy.
Initially, Probate Judge John L. Lohn — since retired — ruled that Sarah’s parents were competent enough to make medical decisions on their daughter’s behalf. Eventually, however, a higher court ordered him to appoint a guardian.
The family responded by fleeing the country, choosing instead to seek alternative medical treatment in Mexico and Canada. Months thereafter, the hospital decided to relinquish guardianship, seeing no point in pursuing the matter further.
Update: Sarah has had MRIs and blood work, and the judge over the last year helped facilitate at least one trip to the Cleveland Clinic. The MRIs did not show any cancer, Her family is continuing to treat her with less invasive alternative medicine. The court formally terminated Sarah’s guardianship on September 24. The judge acknowledged that Sarah, who will turn 13 in November, showed no symptoms of cancer and that she appeared to be healthy.”Read more…
A very rich, powerful, prominent and highly politically connected family seeks FDA approval to work with Dr. Burzinski’s and his cancer treatments on the husband’s (Charlie) absolutely inoperable tumor. This interview with Charlie’s wife is the most candid, riveting, shocking story about the FDA irrational attack on Dr. Burzinski and the American people who seek a choice other than that offered by the Cancer cabal. Jaw dropping! This is the real deal on the FDA. Hold on to your composure!
Excerpt from posts: Following is how we have alleviated many of the symptoms of Lyme Disease. Tea: Burdock Root, Marshamallow, Rose Hips, Dandylion Root, Bitter Wormwood. Sea Weed: 207-565-2907, Citricare 800-622-8664. Immusist 888-702-3315.
VLA comment: For those who are not the new age generation, you may be turned off with his alluding to Crystal and Indigo children. And that he calls it Lymes disease instead of Lyme. (So what!) However, he is right about Lyme disease being a bioweapon. And I certainly would add his protocol to yours. And hopefully yours is the SALT CURE. Most importantly, I have facilitated, many times, the cure for Lyme disease by the Salt Cure. See: www.LymePhotos.com I recommend you watch UNDER OUR SKIN to see how pervasive this epidemic really is:
http://www.underourskin.com/film/
Allie Cashel is the cofounder of sufferingthesilence.com, an online community for people living with chronic disease.
VLA Comment: Riveting story
I have cured Lyme Disease and the numerous entities associated with it with one easy cure. It is called the “Salt Cure”. Salt has always been a revered element. With this cure the body become infused with salt. These bioweapon entities can not live in salt. And since the salt pervades all the tissues, they can’t hide either. Anti biotics not only don’t work and suppress the symptoms but it radically disturbs the gut microbiome which leads to a host of immunological diseases. Go to: www.LymePhotos.com
10% of Caucasians are “non metabolizers”. This means that they cannot metabolize more than 50% of today’s drugs such as adderall, and other SSRIS. It is suspected that the heinous trend of school shootings and suicides are caused by non metabolizers who are given psychiatric drugs without first being tested for their ability to metabolize them. Because this test is not standard of care hospitals and doctors who destroy lives by giving counter indicated medication can not be successfully sued. There is a movement to make this test standard of care but it is being thwarted by the invested pharmacuetical companies who would stand to lose billions of dollars if the public knew.
Description:
The cytochrome p450 (CYP450) family is involved in the metabolism of a significant proportion of currently administered drugs, and genetic variants in cytochrome p450 are associated with altered metabolism of many drugs. It is proposed that genetic testing for cytochrome p450 variants may assist in selecting and dosing drugs that are impacted by these genetic variants.
Drug efficacy and toxicity vary substantially between individuals. Because drugs and doses are typically adjusted to meet individual requirements as needed by using trial and error, clinical consequences may include a prolonged time to optimal therapy and serious adverse events.
Various factors may influence the variability of drug effects, including age, liver function, concomitant diseases, nutrition, smoking, and drug-drug interactions. Inherited (germline) DNA sequence variation (polymorphisms) in genes coding for drug metabolizing enzymes, drug receptors, drug transporters, and molecules involved signal transduction pathways also may have major effects on the activity of those molecules and also on the efficacy and toxicity of the drug.
Pharmacogenomics is the study of how an individual’s genetic inheritance affects the body’s response to drugs. It may be possible to predict therapeutic failures or severe adverse drug reactions in individual patients by testing for important DNA polymorphisms (genotyping) in genes related to the metabolic pathway (pharmacokinetics) or single transduction pathway (pharmacodynamics) of the drug. Potentially, test results could be used to optimize drug choice and/or dose for more effective therapy, avoid serious adverse effects and decrease medical costs.
Some CYP450 enzyme genes are highly polymorphic, resulting in some enzyme variants that have variable metabolic capacities among individuals, and some with little to no impact on activity.
Individuals with a lack of function activity in these enzymes (CYP2C19, CYP2D6, CYP2C9, etc.) can be classified according to how fast they metabolize medications: